The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged 12 years and above with moderate-to-severe atopic dermatitis.

Kyle has had moderate to severe eczema across most of his body since he was an infant. Throughout his life, he’s faced a mix ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

Organon's VTAMA (tapinarof) cream is a first-in-class therapy with new FDA approval for atopic dermatitis in adults and children aged 2 and older.

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

There is a rising demand for dermatological treatments in Saudi Arabia due to various skin conditions, including skin cancers ...

The Albanese Government has ensured thousands of Australians living with severe eczema will continue to have access to ...

The prevalence of eczema in Singapore has been largely stable in the past decade, affecting about one in five children and ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...